📰 Zoe Bolt News
Zoe Bolt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zoe Bolt. Real-time updates on events, politics, business and more.
May 23, 2024
EQS-News: Heidelberg Pharma AG / Key word: Conference Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024...
April 25, 2024
EQS-News: Heidelberg Pharma AG / Key word: Quarterly / Interim Statement Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 25.04.2024 /...
April 5, 2024
EQS-News: Heidelberg Pharma AG / Key word: Miscellaneous Heidelberg Pharma to host R&D Webinar following novel data presented at AACR 05.04.2024 / 09:30 CET/CEST The...
January 26, 2024
Update on Regulatory Review of leriglitazone in the EU
January 10, 2024
Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma
October 19, 2023
17 Oct 2023 STORMs first-in-class investigational drug STC-15 is the first clinical stage molecule specifically targeting an RNA methyltransferase ...
May 11, 2023
UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer UCBs... | May 11, 2023
October 27, 2022
AmbioPharm to provide cGMP peptide synthesis and support for clinical radiopharmaceutical manufacturing Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical
August 9, 2022
09.08.2022 - Ensifentrine met primary and secondary endpoints of evaluating lung function in Phase 3 ENHANCE-2 trial for COPD Top-line Phase 3 ENHANCE-1 data expected around the end of 2022 Conference call today at 8:30 a.m. EDT / 1:30 p.m. ...
August 9, 2022
09.08.2022 - Statistically significant improvements in key measures of lung function 42% reduction in rate of exacerbations over 24 weeks Well tolerated with safety results similar to placebo Conference call today at 8:30 a.m. EDT / 1:30 p.m. BST LONDON and ...